Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Feasibility, Safety and Predictors of Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Discharged “Early” after Intensive Induction Therapy

Cameron Hunter, Wei Cheng, Stephanie Halene, Lourdes Mendez, Nikolai A. Podoltsev, Amer M. Zeidan, Lisa Barbarotta, Rory M. Shallis

Blood (2023) 142 (Supplement 1): 589.

https://doi.org/10.1182/blood-2023-182989

Published: 2023

Journal Articles

North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia

Alexander B Pine, MDPhD, Eun-Ju Lee, MD, Mikkael A. Sekeres, MD MS, David P. Steensma, MD, Thomas Prebet, MD, Amy E. DeZern, MD MHS, Rami S. Komrokji, MD, Mark R Litzow, MD, Selina Luger, MD, Richard M. Stone, MD, Harry P Erba, MD PhD, Guillermo Garcia-Manero, MD, Alfred I Lee, MD PhD, Nikolai A. Podoltsev, MDPhD, Lisa Barbarotta, APRN-BC, Jeanne E. Hendrickson, MD, Steven D. Gore, MD, Amer M. Zeidan, MBBS, MHS

Blood (2015) 126 (23): 1138.

https://doi.org/10.1182/blood.V126.23.1138.1138

Published: 2015

Journal Articles

Patterns of Venous Thromboembolism Prophylaxis during Inpatient Treatment of Acute Leukemia: Results of a North American Web-Based Survey

Eun-Ju Lee, MD, B. Douglas Smith, MD, Jessica W Merrey, PharmD, Alfred I Lee, MD PhD, Nikolai A. Podoltsev, MDPhD, Lisa Barbarotta, APRN-BC, Mark R Litzow, MD, Thomas Prebet, MD, Selina Luger, MD, Steven D. Gore, MD, Michael B. Streiff, MD, Amer M. Zeidan, MBBS, MHS

Blood (2015) 126 (23): 4455.

https://doi.org/10.1182/blood.V126.23.4455.4455

Published: 2015

Journal Articles

A Pilot Study Of Sorafenib In Refractory Or Relapsed T-Cell Lymphoma Patients

Juliet Fraser, Frederick Lansigan, MD, Stuart Seropian, Lisa Barbarotta, APRN-BC, Francine M. Foss, MD

Blood (2013) 122 (21): 4356.

https://doi.org/10.1182/blood.V122.21.4356.4356

Published: 2013

Journal Articles

Cutaneous Toxicity Associated with Pralatrexate in Cutaneous and Peripheral T-Cell Lymphoma

Terri L. Parker, MD, Lisa Barbarotta, APRN-BC, Michael Girardi, MD, FAAD, Francine M. Foss, MD

Blood (2012) 120 (21): 3660.

https://doi.org/10.1182/blood.V120.21.3660.3660

Published: 2012

NARROW

Feasibility, Safety and Predictors of Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Discharged “Early” after Intensive Induction Therapy

North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia

Patterns of Venous Thromboembolism Prophylaxis during Inpatient Treatment of Acute Leukemia: Results of a North American Web-Based Survey

A Pilot Study Of Sorafenib In Refractory Or Relapsed T-Cell Lymphoma Patients

Cutaneous Toxicity Associated with Pralatrexate in Cutaneous and Peripheral T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Feasibility, Safety and Predictors of Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia Discharged “Early” after Intensive Induction Therapy

North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia

Patterns of Venous Thromboembolism Prophylaxis during Inpatient Treatment of Acute Leukemia: Results of a North American Web-Based Survey

A Pilot Study Of Sorafenib In Refractory Or Relapsed T-Cell Lymphoma Patients

Cutaneous Toxicity Associated with Pralatrexate in Cutaneous and Peripheral T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only